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Objective: To study inﬂammatory ultrasound (US) features and pain over a 3-month period in hand
osteoarthritis (HOA).
Design: In 25 consecutive HOA patients (mean age 60 years, 76% female), fulﬁlling the American College
of Rheumatology (ACR) criteria, visual analogue scale (VAS) pain scores were collected at baseline and 3
months. In 750 [all ﬁrst carpometacarpal (CMC), metacarpalphalangeal (MCP), proximal interphalangeal
(PIP), distal interphalangeal (DIP) and ﬁrst interphalangeal (IP)] joints, pain was assessed upon palpation
and synovial thickening, effusion and power Doppler signal (PDS) were scored with standardized
methods by US.
Associations between inﬂammatory features and painful joints were analysed using generalized esti-
mated equations to account for patient effects, adjusting for confounders, and presented as odds ratios
(ORs) with 95% conﬁdence intervals (95%CI).
Results: Inﬂammatory US features were seen in (nearly) all patients. The median number (range) of
inﬂammatory joints per patient did not change over time: 9 (0e16) to 9 (2e18). In 18.7% of joints in-
ﬂammatory features were present at both time points; in 20.5% inﬂammatory features occurred only at
baseline or follow-up. Pain decreased over time: median VAS pain 49e39 mm; median number of painful
joints 8e3. Synovial thickening, effusion and PDS were associated with pain upon palpation both at
baseline and follow-up: OR 2.9 (1.4, 5.7), 2.7 (1.7, 4.3), 3.6 (2.1, 6.3) and 7.3 (3.2, 16.5), 3.3 (2.3, 4.7), 4.1
(2.1, 7.9). respectively.
Conclusions: In HOA inﬂammatory US features are stable over time at patient level, but vary on joint
level. Pain diminished after 3 months, while associations between painful joints and inﬂammation seem
to increase, emphasizing the multifactorial aetiology of pain.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Hand osteoarthritis (HOA) is a prevalent disease, causing
considerable pain and disability1, which aetiology is still largely
unknown. Recent studies showed that in HOA inﬂammatory fea-
tures are frequently present and that these features are associated
with pain2,3. It is, however, not known how these inﬂammatory
features behave over time and what the implication of their pres-
ence is.
The clinical course in HOA varies over time with passing epi-
sodes of soft tissue swelling. Therefore it is expected that.C. Kortekaas, Department of
. Box 9600, 2300 RC Leiden,
6752.
ekaas).
s Research Society International. Pinﬂammatory features also change over time. Since pain varies over
time as well, one could hypothesize that ﬂuctuation in pain is due
to variation in inﬂammation. On the other hand, pain is a difﬁcult
feature to understand, since it is a subjective experience inﬂuenced
by genetic predisposition and psychosocial factors4,5.
Since inﬂammatory ultrasound (US) features are present and are
associated with pain, this could be a target for therapy. Few studies
have used inﬂammatory US features to monitor treatment effect on
clinical en inﬂammatory features in HOA. Keen et al. investigated
the efﬁcacy of intra-muscular methylprednisolone in an open study
in patients with HOA over a period of 3 months and observed a
decrease of global pain, but no difference in inﬂammatory features
on patient level6. Klauser et al. injected 78 clinically severe osteo-
arthritic hand joints with hyaluronic acid. Inﬂammatory features
and pain decreased after 4 weeks; no control joints were
investigated7.ublished by Elsevier Ltd. All rights reserved.
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formed to investigate how, on joint level, inﬂammatory features and
their relation to pain evolve over time, which is important to study
treatment effects. Therefore, the objective of the present study is to
investigate how inﬂammatory US features and pain evolve. Since up
till now, clinical trials investigated the effect of a drug for short pe-
riods, we examined evolution during a 3-month period.
Materials and methods
Patient population and OA diagnosis
Consecutive patients were recruited from the rheumatology
outpatient clinic of the Leiden University Medical Centre, a sec-
ondary consultation centre for the region, from December 2008e
January 2010. All patients participated in the EChograﬁe in Hand
Osteoarthritis study (ECHO), a cross-sectional study described
previously2. When this study was started and inﬂammatory fea-
tures appeared to be frequent, the objective of the present study
was formulated and local medical ethics committee approval ob-
tained for this amendment. Therefore only the last 25 patients were
eligible for inclusion.
Patients met the American College of Rheumatology criteria for
HOA8 and had to be 45 years of age. Exclusion criteria were:
trauma or operation of the hands within 6 months, an intra-
articular injection within 3 months prior to inclusion, oral corti-
costeroids 1 month prior to inclusion, positive rheumatoid factor,
carpal tunnel syndrome or any other inﬂammatory joint disease
such as rheumatoid arthritis, psoriatic arthritis or crystal arthrop-
athy. All patients gave written informed consent.
Clinical assessment
Demographic characteristics were collected by standardized
questionnaires. One-hundred millimetre visual analogue scale
(VAS) hand pain was obtained at baseline and 3 months.
During physical examination, the Doyle index (scores ranged 0e
3)9 was assessed at baseline and 3 months by a specialized and
trained nurse in 30 hand joints, being ﬁrst carpometacarpal joints
(CMCJs), ﬁrst interphalangeal joints (IPJs), metacarpalphalangeal
(MCPJs), proximal interphalangeal joints (PIPJs) and distal inter-
phalangeal joints (DIPJs) from both hands. For the analyses, pain
scores were dichotomized in painful versus non-painful joints. No
analgesics (including non-steroidal anti-inﬂammatory drugs) were
allowed 72 h prior to the clinical and US assessment.
Radiographic assessment
Dorsalevolar radiographs of both hands were scored for
osteophytes (0e3) and joint space narrowing (JSN) (0e3) using the
OARSI atlas10 at baseline by a trained reader (MCK).
In addition all PIPJs and DIPJs were scored following the Ver-
bruggen and Veys score11. Erosive HOAwas deﬁned by the presence
of at least one joint in E (¼subchondral erosion) or R (¼remodelling
of subchondral plate) phase.
Films were blinded for patient characteristics and US outcomes.
The intra-reader reliability depicted by the intra-class coefﬁcient
(ICC) was 0.86 for osteophytes, 0.76 for JSN and 0.80 for the
anatomical phases.
US procedure
US was performed on the same day as the clinical assessment by
one experienced ultrasonographer (MCK), scoring together in
consensus in the presence of a second ultrasonographer (WYK) atall visits, using a Toshiba Applio scanner (Toshiba Medical systems,
Tustin, California) with a 10e14 MHz linear array transducer. Both
ultrasonographers were blinded to clinical ﬁndings.
Power Doppler signal (PDS) was assessedwith a pulse repetition
frequency of 13.2 kHz and a medium wall ﬁlter. Settings were
optimized by the application specialist of the manufacturer of the
machine.
All 30 hand joints were scanned on the dorsal side in longitu-
dinal and transverse planes and scored for PDS, synovial thickening
and effusion as described previously2 using a semi-quantitative
scale: 0 ¼ none, 1 ¼ mild, 2 ¼ moderate and 3 ¼ severe (maximal
total score 90)2. Features had to be present in both planes.
Intra-observer reliability was good to almost perfect2.
Statistical analysis
Differences in demographics, self-reported pain, and summated
US features between baseline and 3 months were calculated using
Wilcoxon signed rank test. Proportion statistic was performed us-
ing McNemar analyses.
The association of US features with painful joints was studied
using generalized estimated equations (GEE). Odds ratios (ORs)
were presented with 95% conﬁdence intervals (95%CI). Adjust-
ments were made for patient effects and confounders. We
compared summated scores of US features with VAS pain and
summated painful joints using Spearman’s rank correlation.
Data were analysed using SPSS for Windows, version 20.0 (IBM
SPSS statistics, New York, USA).
Results
Study population
Twenty-ﬁve patients were included [mean (SD) age 60 (8.8)
years, 16 (76%) women, mean (SD) body mass index (BMI) 28.0
(4.3) kg/m2]. Ten patients had erosive HOA. Of two patients data
on physical examination and VAS were missing at baseline (60
joints). All patients had osteophytes and JSN in at least one joint
on radiographs. The median (range) number of joints with
osteophytes and JSN per patient was 16 (2e25) and 19 (3e22),
respectively.
US scores at baseline and after 3 months of follow-up
Nearly all patients [24 (96%) at baseline and 25 (100%) at 3
months] showed inﬂammatory features during the disease course.
Themedian number of joints per patient andmedian total score per
patient with effusion, PDS or synovial thickening did not change
over 3 months (Table I). However, a change in the actual joints that
showed inﬂammatory US features between baseline and 3 months
was seen. Hundred ﬁfty-four of 750 (20.5%) joints had inﬂamma-
tory signs only at one time point (either baseline or follow-up),
60.8% (456 joints) lacked inﬂammatory signs both at baseline and
3months and 18.7% (140 joints) had these signs at both time points.
Effusion was most frequent at baseline and 3 months: 157 and
181 joints respectively. One-hundred and two joints showed effu-
sion at both time points. Synovial thickening was seen in 93 and 92
joints at baseline and follow-up, respectively, 47 joints showed
synovial thickening at both time points. PDSwas found in 70 and 58
joints at baseline and follow-up, respectively, and 27 joints at both
baseline and at 3 months.
So, although there is no change in the total number of joints and
total severity score in US features of inﬂammation after 3months of
follow-up, there is a change observed in joints that show inﬂam-
matory features at baseline and after 3 months.
Table II
The association between US inﬂammatory features and painful joints upon palpa-
tion in 25 patients with HOA: both at baseline, both at follow-up and the prediction
of painful joints at follow-up by US features at baseline
US features Association between
baseline US features
and painful joints
Adjusted OR* (95%CI)
Follow-up US
features and
painful joints
OR* (95%CI)
Baseline US
features and
painful joints
after 3 months
OR* (95%CI)
Synovial
thickening
2.9 (1.4, 5.7) 7.3 (3.2, 16.5) 2.0 (1.1, 3.9)
Effusion 2.7 (1.7, 4.3) 3.3 (2.3, 4.7) 4.8 (2.2, 10.5)
PDS 3.6 (2.1, 6.3) 4.1 (2.1, 7.9) 3.8 (2.7, 5.4)
* Adjusted for age, sex and BMI.
Table I
Clinical and US scores in 30 hand joints of 25 patients with HOA at baseline and after
3 months of follow-up
Baseline*
N ¼ 25
3 months*
N ¼ 25
VAS, mm 49 (1e79) 36 (1e76)y
Painful joints upon palpation per patient, no. 8 (1e23) 3 (0e16) y, z
Patient with inﬂammatory US feature, no. 24 25
Joints per patient with any US inﬂammatory
feature, no.
9 (0e16) 9 (2e18)
PDS
Affected joints, no. 3 (0e7) 2 (0e9)
Total scorex 3 (0e11) 2 (0e14)
Effusion
Affected joints, no. 6 (0e14) 7 (0e17)
Total scorex 6 (0e25) 8 (0e27)
Synovial thickening
Affected joints, no. 3 (0e12) 3 (0e13)
Total scorex 5 (0e23) 4 (0e19)
Abbreviation: no. ¼ number.
* All values are medians (range), unless stated otherwise.
y N ¼ 23, due to missing data of two patients.
z Signiﬁcant difference (P ¼ 0.01) between baseline and 3 months, calculated
using Wilcoxon signed rank test.
x Maximal total score 90.
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As depicted in Table I, global pain as measured with VAS pain
(median) decreased in 3 months’ time, although no statistical sig-
niﬁcance was reached [median VAS pain (49e36, P ¼ 0.16)]. Total
number of painful joints per patient showed a statistically signiﬁ-
cant decrease (8e3, P¼ 0.01). Hundred ninty-nine of 680 individual
joints were painful at baseline and 106 of 750, which was a sta-
tistical signiﬁcant difference (P < 0.0001) at follow-up.
Association between pain and inﬂammatory features as assessed
by US
Previously, we showed in 55 HOA patients that inﬂammatory US
features are associated with pain in hand joints2. Results at baseline
of the present study were in accordance with those of the total
group. These cross-sectional associations were still present after 3
months and tended to be stronger (Table II). In this table adjusted
OR’s are reported. Crude analyses were calculated as well and
rendered comparable results.
When analyses were performed on patient level by correlating
summated inﬂammatory US features with VAS pain and summated
total painful joints at baseline and follow-up, no correlations were
found (data not shown).
Association between inﬂammatory US features at baseline and
painful joints upon palpation at 3 months follow-up
Strong associations between all inﬂammatory features at base-
line and the presence of pain upon palpation in a joint were found
after 3 months (Table II).
Again when analyses were performed on patient level no cor-
relations were found (data not shown).
Discussion
The present study shows that in HOA patients summated in-
ﬂammatory US features remained stable over a 3-month period. At
joint level 19% of hand joints had persistent inﬂammatory features,
while they ﬂuctuated in 20%. Remarkably, pain reduced over time,
while the associations of inﬂammatory features with pain
remained and even tended to grow stronger after 3 months.Mechanisms that could explain ﬂuctuating inﬂammatory fea-
tures in OA have been described. Mechanical stress can induce
matrix degradation leading to the release of aggrecanases and
collagenases and subsequently to activation of chondrocytes, which
are capable of producing proinﬂammatory cytokines leading to
inﬂammatory features12.
Furthermore, crystals such as calciumpyrophosphate and/or
hydroxyapatite, which are frequently found in OA, can lead to
synovitis13.
Other mechanisms that can lead to more persistent inﬂamma-
tion are age and obesity.
Ageing causes changes in chondrocytes leading to the devel-
opment of a senescence-associated secretory phenotype that in-
creases production of many cytokines, chemokines and matrix
metalloproteinases14. Adipose tissue is capable of producing adi-
pokines, which are able to induce inﬂammation15.
In the present study, the decrease in pain can’t be explained by a
decrease of inﬂammation.
An alternative explanation could be a lowered mechanical load
and diminished psychological factors like uncertainty and fear
resulting in perceiving less pain at 3 months. All participants
received education about the disease and principles of chronic pain,
joint protection, and use of assistive devices and splints by a clinical
nurse specialist.
Furthermore, bias could have occurred due to the ﬂuctuating
natural course of the disease. Participants seek medical help when
they experience a lot of complaints. At this time theywere included
in the present study. The decrease in pain could then be a natural
spontaneous decrease in complaints (regression to the mean). In
the clinical trial by Keen et al.6, self-reported pain decreased after 3
months, as in the present study. The question can be raisedwhether
this decrease in pain was due to methylprednisolone use, or this
mechanism. Knowledge on these issues and ﬁndings are important,
and need further research, since imaging modalities studying in-
ﬂammatory features are considered to be very promising tools to
study for instance the efﬁcacy of possible disease modifying OA
drugs. In order to draw solid conclusions towards responses of
these drugs, thorough knowledge of the natural course of disease is
mandatory.
Although patients reported decreased pain after follow-up, the
association of pain on palpation with US features tended to in-
crease. A possible explanation could be a decrease of other causes,
such as psychosocial and mechanical causes, of pain that are not
directly related to inﬂammation. This observation emphasized the
multifactorial origin of pain.
A drawback of this study is the small patient population, which
likely explains the lack of statistical signiﬁcance for the decrease in
VAS pain after 3 months and the lack of association between
summated inﬂammatory features and VAS pain. However, 750
joints are studied in these patients allowing enough power to
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adjusting for within-patient effects and confounders.
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